Phase I/II Study of a Lentigen® CD19 Chimeric Antigen Receptor (CAR) T Cells in Adult patients with relapsed/refractory CD19 Positive Acute Lymphoblastic Leukemia (ALL) using a Closed Transduction System
2022-06-29
عنوان الدراسة
Phase I/II Study of a Lentigen® CD19 Chimeric Antigen Receptor (CAR) T Cells in Adult patients with relapsed/refractory CD19 Positive Acute Lymphoblastic Leukemia (ALL) using a Closed Transduction System
داعم الدراسة
King Faisal Specialist Hospital and Research Centre
دواء الدراسة
CD19-CART
رقم بروتوكول الدراسة
2191207
حالة الدراسة
Completed
موقع الدراسة
KFSH&RC-R
مرحلة الدراسة
1/2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。